The role of systemic, spinal and supraspinal l-arginine–nitric oxide–cGMP pathway in thermal hyperalgesia caused by intrathecal injection of glutamate in mice.
- 28 April 1999
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 38 (6) , 835-842
- https://doi.org/10.1016/s0028-3908(99)00006-4
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin‐1 secretionFEBS Letters, 1995
- Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphoraseEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Intervention with Spinal NMDA, Adenosine, and NO Systems for Pain ModulationAnnals of Medicine, 1995
- Glutamate spinal retrograde sensitization of primary sensory neurons associated with nociceptionNeuropharmacology, 1994
- Spinal Mediators of HyperalgesiaDrugs, 1994
- Nitric oxide: A signal for ADP-ribosylation of proteinsLife Sciences, 1994
- Localization of nitric oxide synthase indicating a neural role for nitric oxideNature, 1990
- IntrathecalN-methyl-d-aspartate (NMDA) activates both nociceptive and antinociceptive systemsBrain Research, 1987
- Intracerebroventricular injections in miceJournal of Pharmacological Methods, 1986
- Ethical guidelines for investigations of experimental pain in conscious animalsPAIN®, 1983